Evidence-Based Interventions to Reduce the Incidence of Common Multidrug-Resistant Gram-Negative Bacteria in an Adult Intensive Care Unit

被引:1
|
作者
Althaqafi, Abdulhakeem [1 ,2 ,3 ]
Yaseen, Muhammad [4 ]
Farahat, Fayssal [5 ,6 ,7 ]
Munshi, Adeeb [1 ,2 ,3 ]
Al-Hameed, Fahad M. [1 ,8 ,9 ]
Alshamrani, Majid M. [7 ,10 ,11 ]
Alsaedi, Asim [1 ,12 ,13 ]
Al-Amri, Abdulfattah [1 ,14 ,15 ]
Chenia, Hafizah [16 ]
Essack, Sabiha Y. [17 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia
[2] King Abdullah Int Med Res Ctr, Infect Dis, Jeddah, Saudi Arabia
[3] King Abdul Aziz Med City, Med Infect Dis, Jeddah, Saudi Arabia
[4] Bradford Teaching Hosp Natl Hlth Serv NHS Fdn Trus, Infect Prevent & Control, Bradford, England
[5] King Saud Bin Abdulaziz Univ Hlth Sci, Publ Hlth & Community Med, Riyadh, Saudi Arabia
[6] Menoufia Univ, Publ Hlth & Community Med, Shibin El Kom, Saudi Arabia
[7] King Abdul Aziz Med City, Infect Prevent & Control, Riyadh, Saudi Arabia
[8] King Abdullah Int Med Res Ctr, Intens Care Unit, Jeddah, Saudi Arabia
[9] King Abdul Aziz Med City, Intens Care Unit, Jeddah, Saudi Arabia
[10] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia
[11] King Abdullah Int Med Res Ctr, Infect Prevent & Control, Riyadh, Saudi Arabia
[12] King Abdullah Int Med Res Ctr, Infect Prevent & Control, Jeddah, Saudi Arabia
[13] King Abdul Aziz Med City, Infect Prevent & Control, Jeddah, Saudi Arabia
[14] King Abdullah Int Med Res Ctr, Microbiol, Jeddah, Saudi Arabia
[15] King Abdul Aziz Med City, Microbiol, Jeddah, Saudi Arabia
[16] Univ Kwazulu Natal, Coll Agr, Sch Life Sci, Discipline Microbiol,Microbiol, Durban, South Africa
[17] Univ Kwazulu Natal, Antimicrobial Res Unit, Durban, South Africa
关键词
saudi arabia; intensive care unit; interventions; incidence; multidrug-resistant; gram-negative bacteria; ANTIMICROBIAL RESISTANCE; ACINETOBACTER-BAUMANNII; STEWARDSHIP; INFECTIONS; IMPACT;
D O I
10.7759/cureus.39979
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Multidrug-resistant Gram-negative bacteria (MDR-GNB) present a significant and escalating hazard to healthcare globally. Context-specific interventions have been implemented for the prevention and control of MDR-GNB in several healthcare facilities. The objective of this study was to implement and evaluate the effectiveness of evidence-based interventions in the incidence and dissemination of MDR-GNB. Methods This was a pre-and post-intervention study conducted in three phases at King Abdulaziz Medical City Jeddah, Saudi Arabia. During Phase-1, the data on each of the four MDR-GNB (Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli) were collected prospectively. Genomic fingerprinting was performed on isolates using enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR) to determine clonality and establish a link between different strains within and between the hospital wards/units. In the second phase, targeted interventions were implemented in the adult intensive care unit (ICU) based on previously determined risk factors and included the education of healthcare workers on hand hygiene, disinfection of patients' surrounding, daily chlorhexidine baths, and disinfection rooms on discharge with hydrogen peroxide fogging after MDR-GNB patients were discharged. An antibiotic restriction protocol was simultaneously implemented as part of the hospital antibiotic stewardship program. In the third phase, the effectiveness of the interventions was evaluated by comparing the incidence rate and clonality (using ERIC-PCR genetic fingerprints) of MDR-GNB before and after the intervention. Results A significant reduction of MDR-GNB was observed in Phase-2 and Phase-3 compared with Phase-1. The mean incidence rate of MDR-GNB per 1000 patient days in Phase-1 (pre-intervention) was 11.08/1000, followed by 6.07 and 3.54/1000 in Phase-2 and Phase-3, respectively. A statistically significant reduction was observed in the incidence rate of MDR-GNB in the adult ICU (P=0.007), whereas no statistically significant decrease (P=0.419) was observed in areas other than the adult ICU. Two A. baumannii strains appear to be circulating within the ICU environment with reduced frequency in Phase-2 and Phase-3 compared to Phase -1. Conclusion There was a significant reduction in the incidence of MDR-GNB in the adult ICU due to the successful implementation of both infection control and stewardship interventions, albeit challenging to ascertain the relative contribution of each.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients
    Cohen, Jonathan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 490 - 491
  • [22] Efficacy of a coordinated strategy for containment of multidrug-resistant Gram-negative bacteria carriage in a Neonatal Intensive Care Unit in the context of an active surveillance program
    Saporito, Laura
    Graziano, Giorgio
    Mescolo, Federica
    Amodio, Emanuele
    Insinga, Vincenzo
    Rinaudo, Grazia
    Aleo, Aurora
    Bonura, Celestino
    Vitaliti, Marcello
    Corsello, Giovanni
    Vitale, Francesco
    Maida, Carmelo Massimo
    Giuffre, Mario
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2021, 10 (01)
  • [23] Multidrug-Resistant Gram-Negative Bacteria Infections in Solid Organ Transplantation
    van Duin, D.
    van Delden, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 31 - 41
  • [24] Multidrug-Resistant Gram-Negative Bacteria Infection Prevention and Control Update
    Mills, John P.
    Marchaim, Dror
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2021, 35 (04) : 969 - 994
  • [25] Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria
    Otsuka, Yasunari
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (03) : 182 - 190
  • [26] MRGN: new classification for multidrug-resistant Gram-negative bacteria
    Kaase, Martin
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2013, 37 (06): : 299 - 304
  • [27] New Antibiotics for the Treatment of multidrug-resistant gram-negative Bacteria
    Probst-Kepper, Michael
    Geginat, Gernot
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2018, 53 (7-8): : 529 - 542
  • [28] How do you solve a problem like multidrug-resistant Gram-negative bacteria?
    Gray, J. W.
    Mahida, N.
    JOURNAL OF HOSPITAL INFECTION, 2016, 92 (01) : 1 - 2
  • [29] Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
    Wang, Chuanhai
    Yang, Deqing
    Wang, Yifan
    Ni, Wentao
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Clinical outcomes of intensive care unit patients infected with multidrug-resistant gram-negative bacteria treated with ceftazidime/avibactam and ceftolozane/tazobactam
    Camila Soares Neves
    Líbia Cristina Rocha Vilela Moura
    Jailton Lobo Da Costa Lima
    Maria Amélia Vieira Maciel
    Brazilian Journal of Microbiology, 2024, 55 : 333 - 341